This Article Full Text Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Farivar, R. S. Articles by Brecher, P. Search for Related Content PubMed PubMed Citation Articles by Farivar, R. S. Articles by Brecher, P. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Hazardous Substances DB LOSARTAN POTASSIUM PHENYLEPHRINE

(Hypertension. 1995;25:809-813.)
© 1995 American Heart Association, Inc.

Articles

Effect of Angiotensin II Blockade on the Fibroproliferative Response to Phenylephrine in the Rat Heart

R. Saeid Farivar; Dennis C. Crawford; Aram V. Chobanian; Peter Brecher

From the Boston (Mass) University School of Medicine.

Correspondence to Peter Brecher, PhD, Boston University School of Medicine, 80 E Concord St, Boston, MA 02118.

Abstract In this study we infused phenylephrine into adult Wistar rats and used losartan to test for a possible role of angiotensin II in the phenylephrine-induced fibrosis. Phenylephrine, given by Alzet minipumps at a rate of 25 mg · kg^-1 · d^-1, produced a rapid and striking fibrotic response that was obvious after 1 day and progressed throughout a 3-day infusion period. Northern and Western blot analyses showed large increases in cardiac fibronectin expression and atrial natriuretic peptide mRNA, corresponding to fibroblast proliferation and myocyte hypertrophy, respectively. Cardiac fibrosis, fibronectin mRNA, and atrial natriuretic peptide mRNA were blocked by prazosin (7 mg · kg^-1 · d^-1). Administration of losartan (10 mg · kg^-1 · d^-1) resulted in a threefold decrease in interstitial and perivascular fibroblast proliferation, as measured by proliferating cell nuclear antigen immunoreactivity (P<.05), a marked reduction of fibronectin mRNA in the heart, and a moderate reduction of cardiac atrial natriuretic peptide mRNA. The data suggest that effects mediated by ₁-adrenergic and angiotensin type 1 receptors may promote cardiac fibrosis.

Key Words: fibrosis • angiotensin II • hypertension, experimental • extracellular matrix • receptors, adrenergic • losartan

This article has been cited by other articles:

				F. J. Ramires, V. M. Salemi, B. M Ianni, F. Fernandes, D. G Martins, A. Billate, E. Cunha NETO, and C. Mady Aldosterone Antagonism in an Inflammatory State: Evidence for Myocardial Protection Journal of Renin-Angiotensin-Aldosterone System, September 1, 2006; 7(3): 162 - 167. [Abstract] [PDF]

				C. F. Deschepper, I. Boutin-Ganache, A. Zahabi, and Z. Jiang In Search of Cardiovascular Candidate Genes: Interactions Between Phenotypes and Genotypes Hypertension, February 1, 2002; 39(2): 332 - 336. [Abstract] [Full Text] [PDF]

				S. S. Salvi {alpha}1-Adrenergic Hypothesis for Pulmonary Hypertension Chest, June 1, 1999; 115(6): 1708 - 1719. [Abstract] [Full Text] [PDF]

				R. S. Farivar and P. Brecher Salicylate Is a Transcriptional Inhibitor of the Inducible Nitric Oxide Synthase in Cultured Cardiac Fibroblasts J. Biol. Chem., December 6, 1996; 271(49): 31585 - 31592. [Abstract] [Full Text] [PDF]

				S.-M. Yu, S.-Y. Tsai, J.-H. Guh, F.-N. Ko, C.-M. Teng, and J. T. Ou Mechanism of Catecholamine-Induced Proliferation of Vascular Smooth Muscle Cells Circulation, August 1, 1996; 94(3): 547 - 554. [Abstract] [Full Text]